Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Hospital

RSS  

Articles

  • News Briefs

    One in three (33%) U.S. adults who have been prescribed drugs to take on a regular basis reported that they often or very often are noncompliant with the treatment regimen, according to a recent Harris Interactive on-line survey.
  • OHRP offers guidance on review of trial web sites

    In late September, OHRP issued guidance concerning IRB review of clinical trial web sites. The guidance, which can be viewed at OHRPs web site, states that IRB review is required when information on a clinical trial web site includes more information than the study title, the purpose of the study, the protocol summary, basic eligibility criteria, study site locations, and how to get more information on the study.
  • Is sharing results a moral obligation?

    Are investigators morally obligated to provide research participants with the chance to see the results from the studies in which they enroll and should IRBs require them to do so?
  • Hurricane research proposals surge

    One unexpected result from Hurricane Katrina has been a sharp increase in proposals for social-behavioral studies, as social scientists seek to find out how Katrina survivors and evacuees have responded to the disaster.
  • When disaster strikes: In Katrina’s wake, IRBs struggle to regroup

    By now, everyone has seen footage of the horrible damage wrought by Hurricane Katrina on the Gulf Coast more than 1,000 people dead, more than a million displaced, cities flooded and left in ruins.
  • Can Alzheimer’s patients participate in research?

    Is it ethical to enroll an elderly person with Alzheimers disease in a new research study, even if he or she doesnt really understand what it entails? What if the research has real risks, is unlikely to benefit the patient, but could lead to advances that will help future patients with Alzheimers?
  • Clinical results too good to be true?

    Clinical trials that show a treatment effect early on face a dilemma. If the effect is real, one ethical argument goes, then it is imperative to give all involved access to the drug as quickly as possible, starting with the placebo group.
  • Survey: Stroke patients favor emergency research

    A survey of patients who had suffered strokes found that most would be willing to participate in emergency research for stroke treatments, and if incapacitated, would accept surrogate decisions about enrollment by family members or even their doctors.
  • Effective error reporting: Quality leaders share cutting-edge strategies

    Are dangerous errors going undetected at your organization? Or are some types of errors being carefully tracked, but without action taken to prevent similar mistakes?
  • Practicing defensive medicine not uncommon

    Although the prevalence of defensive medicine unnecessary tests, referrals, treatments, or avoidance of some patients altogether out of fear of malpractice litigation has been the subject of debate, a new study reports hundreds of physicians in Pennsylvania say they practice defensive medicine regularly.